Nuclear receptors as drug targets for metabolic disease.

Advanced Drug Delivery Reviews
Ira G Schulman

Abstract

Nuclear hormone receptors comprise a superfamily of ligand-activated transcription factors that control development, differentiation, and homeostasis. Over the last 15 years a growing number of nuclear receptors have been identified that coordinate genetic networks regulating lipid metabolism and energy utilization. Several of these receptors directly sample the levels of metabolic intermediates including fatty acids and cholesterol derivatives and use this information to regulate the synthesis, transport, and breakdown of the metabolite of interest. In contrast, other family members sense metabolic activity via the presence or absence of interacting proteins. The ability of these nuclear receptors to impact metabolism will be discussed and the challenges facing drug discovery efforts for this class of targets will be highlighted.

References

May 1, 1995·Genes & Development·P J WillyD J Mangelsdorf
Aug 1, 1994·The Journal of Experimental Medicine·W J de VilliersS Gordon
Dec 15, 1995·Cell·D J MangelsdorfR M Evans
Feb 7, 1997·The Journal of Biological Chemistry·J M LehmannT M Willson
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·B M FormanR M Evans
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S A KliewerJ M Lehmann
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·B M FormanR M Evans
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B A JanowskiD J Mangelsdorf
Jun 8, 1999·The Journal of Clinical Investigation·S KerstenW Wahli
Oct 19, 1999·The Journal of Clinical Investigation·H H Hobbs, D J Rader
Nov 30, 1999·Journal of Leukocyte Biology·W J de Villiers, E J Smart
Dec 22, 1999·Current Opinion in Biotechnology·J J Repa, D J Mangelsdorf
Feb 23, 2000·The Journal of Clinical Investigation·Y Luo, A R Tall
Jun 20, 2000·The Journal of Biological Chemistry·P CostetA R Tall
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·A VenkateswaranP Tontonoz
Nov 23, 2000·Genes & Development·J R SchultzB Shan
Jan 10, 2001·Proceedings of the National Academy of Sciences of the United States of America·B A LaffitteP Tontonoz
Mar 10, 2001·The Journal of Clinical Investigation·S AlbertiJ A Gustafsson
Mar 10, 2001·Cell·C K Glass, J L Witztum
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·W R OliverT M Willson
May 8, 2001·Annual Review of Biophysics and Biomolecular Structure·A C SteinmetzD Moras
Jun 28, 2001·Physiological Reviews·P M Yen
Sep 20, 2001·The Journal of Biological Chemistry·Y ZhangD J Mangelsdorf
Dec 1, 2001·Science·A ChawlaD J Mangelsdorf
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·Charles W JoyceSilvia Santamarina-Fojo
Jan 16, 2002·The Journal of Biological Chemistry·Sean B JosephPeter Tontonoz
Mar 20, 2002·The Journal of Biological Chemistry·Joyce J RepaDavid J Mangelsdorf
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sean B JosephPeter Tontonoz
Aug 24, 2002·The Journal of Biological Chemistry·George E O MuscatIra G Schulman
Aug 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Rajendra K TangiralaIra G Schulman
Aug 28, 2002·Circulation·Gertrud U SchusterJan-Ake Gustafsson
Nov 2, 2002·Nature Medicine·Andrew C Li, Christopher K Glass
Nov 5, 2002·The Journal of Biological Chemistry·Guoqing CaoGarret J Etgen
Nov 21, 2002·Pharmacology & Therapeutics·Heike SchäckeKhusru Asadullah
Jan 4, 2003·Nature Reviews. Immunology·Siamon Gordon

❮ Previous
Next ❯

Citations

Nov 8, 2012·Journal of Medicinal Chemistry·Estel la BuscatóEwgenij Proschak
Aug 28, 2012·Human Molecular Genetics·Magali DumontM Flint Beal
May 5, 2012·Journal of Lipid Research·Peter J GilliesJohn P Vanden Heuvel
Mar 12, 2013·PPAR Research·Satoru MatsudaYasuko Kitagishi
Jan 21, 2016·Expert Opinion on Drug Metabolism & Toxicology·Erika CecchinGiuseppe Toffoli
Sep 25, 2012·Trends in Pharmacological Sciences·Stefano FiorucciAngela Zampella
May 9, 2012·Bioorganic & Medicinal Chemistry Letters·Romain NoelTheodore M Kamenecka
Jan 3, 2012·The Journal of Nutritional Biochemistry·Hung-Tsung WuJuei-Tang Cheng
Oct 3, 2012·Cell Biochemistry and Function·Gianella CaiozziMarie-Louise Ricketts
Jun 1, 2012·Molecular Nutrition & Food Research·Gamze AydemirRalph Rühl
Mar 1, 2013·Biological Reviews of the Cambridge Philosophical Society·Victor A CortesAttilio Rigotti
Jun 8, 2012·Chemical Biology & Drug Design·Vinícius G Maltarollo, Káthia M Honório
Oct 22, 2011·Bioorganic & Medicinal Chemistry·Yukihiro ItohYuichi Hashimoto
Jun 7, 2011·Toxicology Letters·Marcin RatajewskiJarosław Dastych
Feb 7, 2014·Critical Reviews in Food Science and Nutrition·Gu ChenShang-Tian Yang
May 25, 2016·Molecular Pharmacology·Neil J McKenna
Dec 25, 2016·Journal of Lipid Research·Shimpi BediHeather A Hostetler
Feb 13, 2018·Cellular and Molecular Life Sciences : CMLS·Stefano Sala, Christophe Ampe
Jul 24, 2018·Nucleosides, Nucleotides & Nucleic Acids·Jingjing Li, Yi-Ping Liu
Nov 26, 2014·Nuclear Receptor Signaling·Carly S FilgueiraPaul Webb
Jun 21, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Sarah R BreevoortIra G Schulman
Jan 17, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Irena D Ignatova, Ira G Schulman
Mar 22, 2019·PLoS Pathogens·Chrissy M Leopold WagerLarry S Schlesinger
Jun 24, 2017·Cellular and Molecular Life Sciences : CMLS·Dimitrios GkikasPanagiotis K Politis
Feb 9, 2018·Endocrinology·Bharti Jaiswal, Ashish Gupta
Sep 27, 2018·Frontiers in Endocrinology·Ivan CasaburiVincenzo Pezzi
Apr 9, 2019·Journal of Cellular and Molecular Medicine·Guozhu YeSijun Dong
Mar 16, 2017·Proceedings of the National Academy of Sciences of the United States of America·Xueli WangZhen Zou
Oct 11, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Bo ZhangKeijiro Saku
Mar 3, 2021·European Journal of Medicinal Chemistry·Zonghui MaDailin Liang
May 11, 2021·International Journal of Biological Macromolecules·Katarzyna SołtysAndrzej Ożyhar
Jun 29, 2021·Journal of Diabetes and Metabolic Disorders·Mohammad Bagher SadeghiSaman Sargazi

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

© 2021 Meta ULC. All rights reserved